Search results
Results from the WOW.Com Content Network
PRL-8-53 is a nootropic substituted phenethylamine that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.
4-Bromobenzaldehyde, or p-bromobenzaldehyde, is an organobromine compound with the formula BrC 6 H 4 CHO. It is one of three isomers of bromobenzaldehyde . [ 3 ] It displays reactivity characteristic of benzaldehyde and an aryl bromide .
Methyl benzoate is an organic compound. It is an ester with the chemical formula C 6 H 5 COOCH 3, sometimes abbreviated as PhCO 2 Me, where Ph and Me are phenyl and methyl, respectively. Its structure is C 6 H 5 −C(=O)−O−CH 3. It is a colorless liquid that is poorly soluble in water, but miscible with organic solvents.
[3] Bromobenzene is used to introduce a phenyl group into other compounds. One method involves its conversion to the Grignard reagent, phenylmagnesium bromide. This reagent can be used, e.g. in the reaction with carbon dioxide to prepare benzoic acid. [4] Other methods involve palladium-catalyzed coupling reactions, such as the Suzuki reaction.
Ethyl ester of α-bromoisovaleric acid (ethyl 2-bromo-3-methylbutyrate) — 20 mg; Phenobarbital — 18.26 mg; Peppermint oil — 1.42 mg; Inactive ingredients: stabilizer, ethanol 96%, purified water. According to the Farmak product label, the composition of 1 tablet is as follows: [10] Ethyl ester of α-bromoisovaleric acid — 12.42 mg
Monobromotoluene isomers [1] [2] [3] Common name Structure Systematic name: 1-bromo-2-methylbenzene 1-bromo-3-methylbenzene 1-bromo-4-methylbenzene Molecular formula: C 7 H 7 Br (C 6 H 4 BrCH 3) Molar mass: 171.03 g/mol Appearance colorless liquid colorless liquid white crystalline solid CAS number [95-46-5] [591-17-3]
SR9009, also known as Stenabolic, is a research drug that was developed by professor Thomas Burris of the Scripps Research Institute as an agonist of Rev-ErbA (i.e., increases the constitutive repression of genes regulated by Rev-ErbA) [1] with a half-maximum inhibitory concentration (IC 50) = 670 nM for Rev-ErbAα and IC 50 = 800 nM for Rev-ErbAβ. [2]
Methyl 4-bromophenylacetate is made from 4-bromophenylacetic acid by Fischer esterification, refluxing it with methanol acidified with sulfuric acid. [3] An ethyl ester can be made in an analogous way using ethanol instead of methanol. [4] A hydrazone derivative, 2-(4-bromophenyl)acetohydrazide, is made by refluxing the methyl ester with ...